These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Negative pressure dressings for severe hidradenitis suppurativa (acne inversa): a case report. Walls B; Mohammad S; Campbell J; Archer L; Beale J J Wound Care; 2010 Oct; 19(10):457-60. PubMed ID: 20948495 [TBL] [Abstract][Full Text] [Related]
44. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study. Calao M; Wilson JL; Spelman L; Billot L; Rubel D; Watts AD; Jemec GBE PLoS One; 2018; 13(7):e0200683. PubMed ID: 30040827 [TBL] [Abstract][Full Text] [Related]
45. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States. Garg A; Birabaharan M; Strunk A J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240 [TBL] [Abstract][Full Text] [Related]
46. Current understanding and management of hidradenitis suppurativa. Krbec AC J Am Acad Nurse Pract; 2007 May; 19(5):228-34. PubMed ID: 17489955 [TBL] [Abstract][Full Text] [Related]
47. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Miller IM; McAndrew RJ; Hamzavi I Dermatol Clin; 2016 Jan; 34(1):7-16. PubMed ID: 26617352 [TBL] [Abstract][Full Text] [Related]
48. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation. Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976 [TBL] [Abstract][Full Text] [Related]
49. The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities. Bettoli V; Pasquinucci S; Caracciolo S; Piccolo D; Cazzaniga S; Fantini F; Binello L; Pintori G; Naldi L J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1965-1970. PubMed ID: 27136185 [TBL] [Abstract][Full Text] [Related]
50. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. van der Zee HH; Laman JD; Boer J; Prens EP Exp Dermatol; 2012 Oct; 21(10):735-9. PubMed ID: 22882284 [TBL] [Abstract][Full Text] [Related]
54. Hidradenitis Suppurativa: A Case Study. Kendall C Plast Surg Nurs; 2018; 38(2):46-47. PubMed ID: 29846335 [TBL] [Abstract][Full Text] [Related]
55. Clinical features of hidradenitis suppurativa and Crohn disease: what do these two entities have in common? Vilarrasa Rull E; González Lama Y Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():21-26. PubMed ID: 28081766 [TBL] [Abstract][Full Text] [Related]
56. Demographic and clinical features of hidradenitis suppurativa in Korea. Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH; J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846 [TBL] [Abstract][Full Text] [Related]
57. Hidradenitis suppurativa: Current and emerging treatments. Goldburg SR; Strober BE; Payette MJ J Am Acad Dermatol; 2020 May; 82(5):1061-1082. PubMed ID: 31604100 [TBL] [Abstract][Full Text] [Related]
58. Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018. Posso-De Los Rios CJ; Sarfo A; Ghias M; Alhusayen R; Hamzavi I; Lowes MA; Alavi A Exp Dermatol; 2019 Jul; 28(7):769-775. PubMed ID: 30924968 [TBL] [Abstract][Full Text] [Related]